- July 23, 2020
9:00 AM - 2:00 PM ET
The Food and Drug Administration (FDA or Agency) is announcing a virtual public meeting to discuss proposed recommendations for the reauthorization of the Prescription Drug User Fee Act (PDUFA) for fiscal years (FYs) 2023 through 2027. The virtual public meeting will be held on July 23, 2020, from 9 a.m. to 2 p.m. For more background information on the meeting or to submit comments, please see the Federal Register notice with assigned docket FDA-2010-N-0128 issued on June 8, 2020.
If you would like to attend the meeting, please register on Eventbrite before June 23, 2020 so that FDA may have an approximate count of attendees. Registrants will receive instructions to access the live webcast of the virtual meeting.
The webcast information, meeting agenda, additional materials and any other updates will also be posted to this website as they become available.